CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents
- 1 July 1997
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 18 (4) , 437-444
- https://doi.org/10.1016/s0165-6147(97)90677-5
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICSAnnual Review of Pharmacology and Toxicology, 1997
- PROTEIN PRENYLATION: Molecular Mechanisms and Functional ConsequencesAnnual Review of Biochemistry, 1996
- Photoreactive Analogues of Prenyl Diphosphates as Inhibitors and Probes of Human Protein Farnesyltransferase and Geranylgeranyltransferase Type IPublished by Elsevier ,1995
- Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeuticCell, 1994
- Characterization of recombinant human farnesyl-protein transferase: Cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferasesBiochemistry, 1993
- Ras C-terminal processing enzymes—New drug targets?Cell, 1991
- Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptidesCell, 1990
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989
- The ras gene family and human carcinogenesisMutation Research/Reviews in Genetic Toxicology, 1988
- ras GENESAnnual Review of Biochemistry, 1987